Progression significance for low-level aberrant B-lymphoblasts in chronic myeloid leukaemia patients

Haoren Wang; Huijun Wang; Yuanyuan Li; Bin Zheng; Qiuyun Fang; Yan Li; Yuntao Liu; Runxia Gu; Ying Wang; Yingchang Mi; Bingcheng Liu; Hui Wei; Jianxiang Wang

doi:10.1002/ctm2.70524

Clinical and Translational Medicine ›› 2025, Vol. 15 ›› Issue (11) : e70524 DOI: 10.1002/ctm2.70524

LETTER TO THE JOURNAL

Progression significance for low-level aberrant B-lymphoblasts in chronic myeloid leukaemia patients

Haoren Wang ¹^,²
, Huijun Wang ¹^,²
, Yuanyuan Li ¹^,²
, Bin Zheng ¹^,²
, Qiuyun Fang ¹^,²
, Yan Li ¹^,²
, Yuntao Liu ¹^,²
, Runxia Gu ¹^,²
, Ying Wang ¹^,²
, Yingchang Mi ¹^,²
, Bingcheng Liu ¹^,²
, Hui Wei ¹^,²
, Jianxiang Wang ¹^,²

Author information +

History +

PDF

Cite this article

Download citation ▾

Haoren Wang, Huijun Wang, Yuanyuan Li, Bin Zheng, Qiuyun Fang, Yan Li, Yuntao Liu, Runxia Gu, Ying Wang, Yingchang Mi, Bingcheng Liu, Hui Wei, Jianxiang Wang. Progression significance for low-level aberrant B-lymphoblasts in chronic myeloid leukaemia patients. Clinical and Translational Medicine, 2025, 15(11): e70524 DOI:10.1002/ctm2.70524

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Brioli A, Lomaia E, Fabisch C, et al. Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era—analysis of the European LeukemiaNet Blast Phase Registry. Leukemia. 2024; 38: 1072-1080.

[2]	Khoury JD, Solary E, Abla O, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms. Leukemia. 2022; 36: 1703-1719.

[3]	El Rassi F, Bergsagel JD, Arellano M, et al. Predicting early blast transformation in chronic-phase chronic myeloid leukemia: is immunophenotyping the missing link? Cancer. 2015; 121: 872-875.

[4]	Vijayasekharan K, Chatterjee G, Ramanathan S, et al. Sudden blast phase in pediatric chronic myeloid leukemia-chronic phase with abnormal lymphoid blasts detected by flow cytometry at diagnosis: can it be considered a warning sign? Cytometry Part B Clin. 2021; 100: 345-351.

[5]	Vrotsos E, Gorgan M, DiGiuseppe JA. Detection of small abnormal B-lymphoblast populations at diagnosis of chronic myelogenous leukemia, BCR-ABL1+: incidence, phenotypic features, and clinical implications. Cytometry B Clin Cytom. 2017; 92: 275-278.

[6]	Soma L, Oehler VG, Ding C, Cherian S. Small abnormal B lymphoid blast populations in chronic myelogenous leukemia at diagnosis: does this finding indicate an accelerated course? Cytometry B Clin Cytom. 2016; 90: 440-448.

[7]	Arber DA, Orazi A, Hasserjian RP, et al. International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022; 140: 1200-1228.

[8]	Barge L, Cleary R, Morris K, Simleit E. Incidence and immunophenotype of abnormal lymphoblast populations at diagnosis of chronic myeloid leukaemia in chronic phase. J Hematopathol. 2022; 15: 51-56.

RIGHTS & PERMISSIONS

2025 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.